Weiss Eric Stanton’s Latest Purchase Signals Confidence Amid Volatility
Weiss Eric Stanton, a relatively quiet shareholder who has been buying Core Scientific shares since early 2026, added 7,000 more shares on August 18. The transaction, executed at a weighted average price of $19.19, brings his holdings to 259,262 shares—just shy of 0.04 % of the outstanding shares. While the absolute number is modest, the timing is notable. The stock is trading near a 52‑week low of $13.14 and has rebounded 35.65 % year‑to‑date, suggesting a cautious yet optimistic stance by a long‑term investor.
Implications for Investors
Stanton’s purchase follows a pattern of disciplined buying during periods of price decline. In March he bought 7,000 shares at $14.53, and again in February he added 18,575 shares at no price (likely a pre‑payment or grant). His recent buy at $19.19 comes after a brief rally and a 7 % week‑to‑week drop, indicating that he may view the dip as an attractive entry point. For the broader investor community, the move may serve as a subtle endorsement of Core Scientific’s long‑term trajectory, especially as the company continues to expand its blockchain and AI services in a competitive market.
What It Means for Core Scientific’s Future
Core Scientific’s fundamentals remain mixed. The firm posted a 35.65 % year‑to‑year gain, but the price‑earnings ratio is negative at –6.83, reflecting ongoing investment in growth over profitability. The recent insider buying by Stanton, coupled with the high social‑media buzz (58.15 %) and positive sentiment (+1), suggests that the market is still receptive to the company’s strategic direction. However, the heavy selling by senior executives—most notably Todd DuChene’s cumulative 21,000‑share sale at around $20—underscores potential liquidity concerns or a strategic shift in ownership structure. Investors should weigh the balancing act between insider confidence and executive divestiture when forecasting next‑quarter earnings and capital allocation.
Profile: Weiss Eric Stanton – The Opportunistic Investor
Stanton’s transaction history reveals a pattern of opportunistic buying during market downturns. His first significant purchase in February 2026—18,575 shares—was executed at no disclosed price, perhaps a grant or pre‑payment. In March, he added 7,000 shares at $14.53, and again in August, he bought 7,000 shares at $19.19. These purchases demonstrate a willingness to invest in Core Scientific during volatile periods, suggesting a long‑term commitment to the company’s blockchain and AI initiatives. Unlike some executives who have sold large blocks, Stanton’s modest, incremental buying approach signals a belief in the company’s upside potential.
Bottom Line
Weiss Eric Stanton’s latest share acquisition, while numerically small, carries a narrative of confidence in Core Scientific’s growth prospects amid a backdrop of executive selling. For investors, it is a reminder that insider activity can provide nuanced signals: opportunistic buying during dips may portend a bullish outlook, whereas significant sales from senior leaders warrant closer scrutiny of future capital needs and strategic priorities.
| Date | Owner | Transaction Type | Shares | Price per Share | Security |
|---|---|---|---|---|---|
| 2026-08-18 | Weiss Eric Stanton () | Buy | 7,000.00 | 19.19 | Common Stock |
